Literature DB >> 16037693

Inhibition of glutamine synthetase triggers apoptosis in asparaginase-resistant cells.

Bianca Maria Rotoli1, Jacopo Uggeri, Valeria Dall'Asta, Rossana Visigalli, Amelia Barilli, Rita Gatti, Guido Orlandini, Gian C Gazzola, Ovidio Bussolati.   

Abstract

The resistance to L-asparaginase (ASNase) has been associated to the overexpression of asparagine synthetase (AS), although the role played by other metabolic adaptations has not been yet defined. Both in ASNase-sensitive Jensen rat sarcoma cells and in ARJ cells, their ASNase-resistant counterparts endowed with a five-fold increased AS activity, ASNase treatment rapidly depletes intracellular asparagine. Under these conditions, cell glutamine is also severely reduced and the activity of glutamine synthetase (GS) is very low. After 24 h of treatment, while sensitive cells have undergone massive apoptosis, ARJ cells exhibit a marked increase in GS activity, associated with overexpression of GS protein but not of GS mRNA, and a partial restoration of glutamine and asparagine. However, when ARJ cells are treated with both ASNase and L-methionine-sulfoximine (MSO), an inhibitor of GS, no restoration of cell amino acids occurs and the cell population undergoes a typical apoptosis. No toxicity is observed upon MSO treatment in the absence of ASNase. The effects of MSO are not referable to depletion of cell glutathione or inhibition of AS. These findings indicate that, in the presence of ASNase, the inhibition of GS triggers apoptosis. GS may thus constitute a target for the suppression of ASNase-resistant phenotypes. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16037693     DOI: 10.1159/000087238

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  16 in total

1.  [Expression of asparagine synthetase in relapsed or refractory extranodal NK/T cell lymphoma].

Authors:  Shao-Jie Wu; Yu-Fa Li; Yu-Jue Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

2.  Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

Authors:  Lise Willems; Nathalie Jacque; Arnaud Jacquel; Nathalie Neveux; Thiago Trovati Maciel; Mireille Lambert; Alain Schmitt; Laury Poulain; Alexa S Green; Madalina Uzunov; Olivier Kosmider; Isabelle Radford-Weiss; Ivan Cruz Moura; Patrick Auberger; Norbert Ifrah; Valérie Bardet; Nicolas Chapuis; Catherine Lacombe; Patrick Mayeux; Jérôme Tamburini; Didier Bouscary
Journal:  Blood       Date:  2013-09-06       Impact factor: 22.113

3.  The eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment.

Authors:  Gabriel J Wilson; Piyawan Bunpo; Judy K Cundiff; Ronald C Wek; Tracy G Anthony
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-03       Impact factor: 4.310

4.  The eIF2 kinase GCN2 is essential for the murine immune system to adapt to amino acid deprivation by asparaginase.

Authors:  Piyawan Bunpo; Judy K Cundiff; Rachel B Reinert; Ronald C Wek; Carla J Aldrich; Tracy G Anthony
Journal:  J Nutr       Date:  2010-09-22       Impact factor: 4.798

5.  Binding of nickel to testicular glutamate-ammonia ligase inhibits its enzymatic activity.

Authors:  Yingbiao Sun; Young Ou; Min Cheng; Yibing Ruan; Frans A van der Hoorn
Journal:  Mol Reprod Dev       Date:  2011-01-20       Impact factor: 2.609

Review 6.  Inborn error of amino acid synthesis: human glutamine synthetase deficiency.

Authors:  Johannes Häberle; Boris Görg; Annick Toutain; Frank Rutsch; Jean-François Benoist; Antoinette Gelot; Annie-Laure Suc; Hans Georg Koch; Freimut Schliess; Dieter Häussinger
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

7.  Cell-cycle inhibition by Helicobacter pylori L-asparaginase.

Authors:  Claudia Scotti; Patrizia Sommi; Maria Valentina Pasquetto; Donata Cappelletti; Simona Stivala; Paola Mignosi; Monica Savio; Laurent Roberto Chiarelli; Giovanna Valentini; Victor M Bolanos-Garcia; Douglas Scott Merrell; Silvia Franchini; Maria Luisa Verona; Cristina Bolis; Enrico Solcia; Rachele Manca; Diego Franciotta; Andrea Casasco; Paola Filipazzi; Elisabetta Zardini; Vanio Vannini
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

8.  Reduced Ca2+ entry and suicidal death of erythrocytes in PDK1 hypomorphic mice.

Authors:  Michael Föller; Hasan Mahmud; Saisudha Koka; Florian Lang
Journal:  Pflugers Arch       Date:  2007-09-25       Impact factor: 3.657

9.  Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.

Authors:  Wei-Wen Chien; Soraya Allas; Nicolas Rachinel; Pierre Sahakian; Michel Julien; Céline Le Beux; Claire-Emmanuelle Lacroix; Thierry Abribat; Gilles Salles
Journal:  Invest New Drugs       Date:  2014-05-15       Impact factor: 3.850

Review 10.  Ion channels in cell proliferation and apoptotic cell death.

Authors:  F Lang; M Föller; K S Lang; P A Lang; M Ritter; E Gulbins; A Vereninov; S M Huber
Journal:  J Membr Biol       Date:  2005-06       Impact factor: 2.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.